|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 32601 |
FusionGeneSummary for SAMD9_GCLM |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SAMD9_GCLM | Fusion gene ID: 32601 | Hgene | Tgene | Gene symbol | SAMD9 | GCLM | Gene ID | 54809 | 2730 |
| Gene name | sterile alpha motif domain containing 9 | glutamate-cysteine ligase modifier subunit | |
| Synonyms | C7orf5|DRIF1|MIRAGE|NFTC|OEF1|OEF2 | GLCLR | |
| Cytomap | 7q21.2 | 1p22.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | sterile alpha motif domain-containing protein 9SAM domain-containing protein 9expressed in aggressive fibromatosis | glutamate--cysteine ligase regulatory subunitGCS light chainGSC light chaingamma-ECS regulatory subunitgamma-glutamylcysteine synthetase regulatory subunitglutamate-cysteine ligase (gamma-glutamylcysteine synthetase), regulatory (30.8kD)glutamate-cy | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q5K651 | P48507 | |
| Ensembl transtripts involved in fusion gene | ENST00000379958, | ENST00000370238, ENST00000467772, | |
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 3 X 3 X 2=18 |
| # samples | 2 | 3 | |
| ** MAII score | log2(2/8*10)=1.32192809488736 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SAMD9 [Title/Abstract] AND GCLM [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SAMD9 | GO:0034058 | endosomal vesicle fusion | 24029230 |
| Tgene | GCLM | GO:0006536 | glutamate metabolic process | 9841880|9895302 |
| Tgene | GCLM | GO:0006750 | glutathione biosynthetic process | 10395918 |
| Tgene | GCLM | GO:0006979 | response to oxidative stress | 10395918 |
| Tgene | GCLM | GO:0042493 | response to drug | 9895302 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AI133413 | SAMD9 | chr7 | 92730629 | + | GCLM | chr1 | 94354110 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000379958 | ENST00000370238 | SAMD9 | chr7 | 92730629 | + | GCLM | chr1 | 94354110 | - |
| intron-intron | ENST00000379958 | ENST00000467772 | SAMD9 | chr7 | 92730629 | + | GCLM | chr1 | 94354110 | - |
Top |
FusionProtFeatures for SAMD9_GCLM |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SAMD9 | GCLM |
| May play a role in the inflammatory response to tissueinjury and the control of extra-osseous calcification, acting as adownstream target of TNF-alpha signaling. Involved in theregulation of EGR1, in coordination with RGL2. May be involved inendosome fusion. {ECO:0000269|PubMed:16960814,ECO:0000269|PubMed:18094730, ECO:0000269|PubMed:21160498,ECO:0000269|PubMed:24029230}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SAMD9_GCLM |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SAMD9_GCLM |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SAMD9_GCLM |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | GCLM | P48507 | DB00142 | Glutamic Acid | Glutamate--cysteine ligase regulatory subunit | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for SAMD9_GCLM |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | SAMD9 | C0015934 | Fetal Growth Retardation | 1 | CTD_human |
| Hgene | SAMD9 | C0021400 | Influenza | 1 | CTD_human |
| Hgene | SAMD9 | C0021831 | Intestinal Diseases | 1 | CTD_human |
| Hgene | SAMD9 | C0042063 | Urogenital Abnormalities | 1 | CTD_human |
| Hgene | SAMD9 | C0220766 | Congenital hypoplasia of adrenal gland | 1 | CTD_human |
| Hgene | SAMD9 | C1864861 | Tumoral Calcinosis, Normophosphatemic, Familial | 1 | CTD_human;ORPHANET;UNIPROT |
| Hgene | SAMD9 | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | CTD_human |
| Hgene | SAMD9 | C3714514 | Infection | 1 | CTD_human |
| Tgene | GCLM | C0036341 | Schizophrenia | 3 | PSYGENET |
| Tgene | GCLM | C0027051 | Myocardial Infarction | 2 | CTD_human |
| Tgene | GCLM | C0005138 | Berylliosis | 1 | CTD_human |
| Tgene | GCLM | C0033937 | Psychoses, Drug | 1 | PSYGENET |
| Tgene | GCLM | C0036351 | Residual schizophrenia | 1 | PSYGENET |
| Tgene | GCLM | C0036939 | Shared Paranoid Disorder | 1 | PSYGENET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|